Releaf Medical Cannabis Update

THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL

NOTTINGHAM, UK / ACCESSWIRE / June 5, 2023 / Releaf Dispensary Ltd

It is with great pleasure that I make our second public announcement for my Company today.

Releaf is positioning itself to become the number one firm in the UK's medical cannabis space, offering an all-in-one medical cannabis subscription service enabling patients to obtain prescription-strength cannabis via an online consultation.

Our initial funding rounds have all been completed, and were oversubscribed.

Our series C funding round will open on Monday, 26 June 2023, and be for 250,000 shares priced at £12.50 per share.

Our Company has been featured live on Sky News (Live TV), The Sun, The Daily Mail, The Mirror, Vice and The Daily Express. We were one of the most talked about companies in the world following our 4/20 event on 20 April 2023, gaining over 140,000,000 views of our brand in 24 hours and shared by celebrities world wide. We officially revealed on our website and in the press our first brand ambassador, Linda Robson.

We have over 3000 patients who have signed up for Releaf's early access waiting list. This list alone would place us within the top 5 UK cannabis companies on day 1 of clinic launch. Our patient support team are onboarding these patients into our PMR, ready for clinic live.

Our Company has gone from strength to strength, and we are now seeing real growth and traction across all metrics; alongside the completion of our custom patient software that manages the entire supply chain in one system, we are working with consultants to achieve ISO9001 & ISO27001 certifications for our software by the end of July, these are not required but ensure full compliance.

I am so proud of my team, which has grown over the last two months to 18 full-time staff members with 3 more joining this month; I believe that we will be the UK's largest cannabis company based on active patients within 24 months of clinic opening.

Mason Soiza
Director - Releaf Dispensary Ltd
investors@releaf.co.uk
020 3657 3346

Disclaimer: This announcement is for information purposes only and does not constitute or form part of an offer or invitation to acquire or dispose of any securities of Releaf Dispensary Ltd, or constitute a solicitation of any offer to purchase or subscribe for securities in any jurisdiction. All subscription dates are subject to change without notice.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Releaf Dispensary Ltd